Clinical trials
Terminated Phase 3 Idiopathic Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| InterMune | 3 |
| Gilead Sciences | 2 |
| Hoffmann-La Roche | 2 |
| Kyntra Bio | 2 |
| Lakefront Biotherapeutics NV | 2 |
| Duke University | 1 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 1 |
| Weill Medical College of Cornell University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Idiopathic Pulmonary Fibrosis | 14 |
| Pulmonary Fibrosis | 6 |
| Lung Diseases | 3 |
| Lung Diseases, Interstitial | 3 |
| Fibrosis | 2 |
| Idiopathic Interstitial Pneumonias | 2 |
| Hypertension, Pulmonary | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.